35
ATLS,AHA,Rosen & Barkin's 5-Minute Emergency Medicine Consult, 3rd Edition SHOCK THERAPY

Shock Therapy

Embed Size (px)

Citation preview

Page 1: Shock Therapy

ATLS,AHA,Rosen & Barkin's 5-Minute Emergency Medicine Consult, 3rd Edition

SHOCK THERAPY

Page 2: Shock Therapy

Inadequate supply of blood flow to tissues to meet the demands of the tissues

Nutrient requirements are not fulfilled.Toxic metabolites are not removed.If untreated, inevitable progression from

inadequate perfusion to organ dysfunction and ultimately to death

Definition Shock

Page 3: Shock Therapy
Page 4: Shock Therapy

ShockCauses of Shock:

Inadequate oxygen deliveryInadequate respiration and oxygenation

Respiratory failure (mechanical, toxins)Inadequate hemoglobin

Hemorrhage or anemiaInadequate fluid in the vascular system

Hemorrhage or fluid loss (burns, vomiting, diarrhea, sepsis)

Inadequate blood movementCardiac pump failure

Impaired oxygen uptakeBiochemical poisoning (hydrogen cyanide)

Page 5: Shock Therapy

Types of ShockHypovolemic – most common

Hemorrhagic, occult fluid lossCardiogenic

Ischemia, arrhythmia, valvular, myocardial depression

DistributiveAnaphylaxis, sepsis, neurogenic

ObstructiveTension pneumo, pericardial tamponade, PE

Page 6: Shock Therapy

Shock StatesBP CVP PCWP CO SVR

HypovolemiaCardiogenic - LV- RV

Distributive

Obstructive

Page 7: Shock Therapy

Hypovolemic Shock Most common Trauma Blood Loss Occult fluid loss (GI) Burns Pancreatitis Sepsis (distributive, relative hypovolemia)

Page 8: Shock Therapy
Page 9: Shock Therapy

Assessment of Stages of Shock% Blood Volume loss

< 15% 15 – 30% 30 – 40% >40%

HR <100 >100 >120 >140

SBP N N, DBP, postural drop

Pulse Pressure

N or

Cap Refill < 3 sec > 3 sec >3 sec or absent

absent

Resp 14 - 20 20 - 30 30 - 40 >35CNS anxious v. anxious confused lethargicTreatment 1 – 2 L

crystalloid, + maintenance

2 L crystalloid, re-evaluate

2 L crystalloid, re-evaluate, replace blood loss 1:3 crystalloid, 1:1 colloid or blood products. Urine output >0.5 mL/kg/hr

Page 10: Shock Therapy

Cardiogenic ShockThe heart cannot

pump enough blood to meet the metabolic demands of the body.

Page 11: Shock Therapy
Page 12: Shock Therapy

Etiologies

• What are some causes of cardiogenic shock?• AMI

• Sepsis• Myocarditis• Myocardial contusion• Aortic or mitral stenosis, HCM• Acute aortic insufficiency

Page 13: Shock Therapy

Cardiogenic Shock

• Signs:• Cool, mottled skin• Tachypnea • Hypotension• Altered mental status• Narrowed pulse

pressure• Rales, murmur

• Defined as:• SBP < 90 mmHg• CI < 2.2 L/m/m2

• PCWP > 18 mmHg

Page 14: Shock Therapy

Treatment of Cardiogenic Shock• AMI

• Aspirin, beta blocker, morphine, heparin• If no pulmonary edema, IV fluid challenge• If pulmonary edema

• Dopamine – will ↑ HR and thus cardiac work• Dobutamine – May drop blood pressure• Combination therapy may be more effective

• PCI or thrombolytics• RV infarct

• Fluids and Dobutamine (no NTG)• Acute mitral regurgitation or VSD

• Pressors (Dobutamine and Nitroprusside)

Page 15: Shock Therapy

Anaphylactic Shock

• Anaphylaxis – a severe systemic hypersensitivity reaction characterized by multisystem involvement • IgE mediated

• Anaphylactoid reaction – clinically indistinguishable from anaphylaxis, do not require a sensitizing exposure• Not IgE mediated

Page 16: Shock Therapy

• What are some symptoms of anaphylaxis?

Anaphylactic Shock

• First- Pruritus, flushing, urticaria appear

• Next- Throat fullness, anxiety, chest tightness, shortness of breath and lightheadedness

• Finally- Altered mental status, respiratory distress and circulatory collapse

Page 17: Shock Therapy

Anaphylactic ShockDrugs:

Penicillin and related antibiotics Aspirin Trimethoprim-sulfamethoxazole (Bactrim, Septra) Vancomycin NSAIDs

Other: Hymenoptera stings Insect parts and molds X-Ray contrast media (ionic)

Foods and Additives: Shellfish Soy beans Nuts Wheat Milk Eggs Monosodium glutamate Nitrates and nitrites Tartrazine dyes (food colors)

Page 18: Shock Therapy
Page 19: Shock Therapy

• Mild, localized urticaria can progress to full anaphylaxis

• Symptoms usually begin within 60 minutes of exposure

• Faster the onset of symptoms = more severe reaction

• Biphasic phenomenon occurs in up to 20% of patients• Symptoms return 3-4 hours after initial reaction has

cleared• A “lump in my throat” and “hoarseness” heralds

life-threatening laryngeal edema

Anaphylactic Shock

Page 20: Shock Therapy

Anaphylactic Shock- Diagnosis

• Clinical diagnosis• Defined by airway compromise,

hypotension, or involvement of cutaneous, respiratory, or GI systems

• Look for exposure to drug, food, or insect

• Labs have no role

Page 21: Shock Therapy

• ABC’s• Angioedema and respiratory compromise

require immediate intubation• IV, cardiac monitor, pulse oximetry• IVFs, oxygen• Epinephrine• Second line

• Corticosteriods• H1 and H2 blockers

Anaphylactic Shock- Treatment

Page 22: Shock Therapy

• Epinephrine• 0.3 mg IM of 1:1000 (epi-pen) • Repeat every 5-10 min as needed• Caution with patients taking beta blockers- can

cause severe hypertension due to unopposed alpha stimulation

• For CV collapse, 1 mg IV of 1:10,000• If refractory, start IV drip

Anaphylactic Shock- Treatment

Page 23: Shock Therapy

• Corticosteroids• Methylprednisolone 125 mg IV • Prednisone 60 mg PO

• Antihistamines• H1 blocker- Diphenhydramine 25-50 mg IV• H2 blocker- Ranitidine 50 mg IV

• Bronchodilators• Albuterol nebulizer• Atrovent nebulizer• Magnesium sulfate 2 g IV over 20 minutes

• Glucagon• For patients taking beta blockers and with refractory hypotension• 1 mg IV q5 minutes until hypotension resolves

Anaphylactic Shock - Treatment

Page 24: Shock Therapy

Neurogenic Shock

Page 25: Shock Therapy

Neurogenic Shock • Occurs after acute spinal cord injury• Sympathetic outflow is disrupted leaving

unopposed vagal tone• Results in hypotension and bradycardia• Spinal shock- temporary loss of spinal

reflex activity below a total or near total spinal cord injury (not the same as neurogenic shock, the terms are not interchangeable)

Page 26: Shock Therapy

• Loss of sympathetic tone results in warm and dry skin

• Shock usually lasts from 1 to 3 weeks• Any injury above T1 can disrupt the entire

sympathetic system• Higher injuries = worse paralysis

Neurogenic Shock

Page 27: Shock Therapy
Page 28: Shock Therapy

• A,B,Cs• Remember c-spine precautions

• Fluid resuscitation• Keep MAP at 85-90 mm Hg for first 7 days• Thought to minimize secondary cord injury• If crystalloid is insufficient use vasopressors

• Search for other causes of hypotension• For bradycardia

• Atropine• Pacemaker

Neurogenic Shock- Treatment

Page 29: Shock Therapy

Neurogenic Shock- Treatment• Methylprednisolone

• Used only for blunt spinal cord injury• High dose therapy for 23 hours• Must be started within 8 hours• Controversial- Risk for infection, GI bleed

Page 30: Shock Therapy

Obstructive Shock

Page 31: Shock Therapy

Obstructive Shock• Tension pneumothorax

• Air trapped in pleural space with 1 way valve, air/pressure builds up

• Mediastinum shifted impeding venous return• Chest pain, SOB, decreased breath sounds• No tests needed!• Rx: Needle decompression, chest tube

Page 32: Shock Therapy

Obstructive Shock• Cardiac tamponade

• Blood in pericardial sac prevents venous return to and contraction of heart

• Related to trauma, pericarditis, MI• Beck’s triad: hypotension, muffled heart

sounds, JVD• Diagnosis: large heart CXR, echo• Rx: Pericardiocentisis

Page 33: Shock Therapy

Obstructive Shock• Pulmonary embolism

• Virscow triad: hypercoaguable, venous injury, venostasis

• Signs: Tachypnea, tachycardia, hypoxia• Low risk: D-dimer• Higher risk: CT chest or VQ scan• Rx: Heparin, consider thrombolytics

Page 34: Shock Therapy

Obstructive Shock• Aortic stenosis

• Resistance to systolic ejection causes decreased cardiac function

• Chest pain with syncope• Systolic ejection murmur• Diagnosed with echo• Vasodilators (NTG) will drop pressure!• Rx: Valve surgery

Page 35: Shock Therapy

ReferencesClinical Anesthesia 3rd Ed. Morgan et al.

Lange Medical / McGraw Hill, 2002Anesthesiology Review 3rd Ed. Faust, R.

Churchill-Livingstone, 2002Rivers, E. et al. NEJM 2001; 345 (19): 1368 –

77SAFE Investigators. NEJM 2004; 350: 2247 -

56